Choate Investment Advisors Increases Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Choate Investment Advisors increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 61.8% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 2,370 shares of the medical equipment provider’s stock after buying an additional 905 shares during the quarter. Choate Investment Advisors’ holdings in Intuitive Surgical were worth $1,237,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the stock. M & L Capital Management Ltd purchased a new position in Intuitive Surgical in the fourth quarter valued at about $9,239,000. Frank Rimerman Advisors LLC lifted its stake in Intuitive Surgical by 0.6% in the fourth quarter. Frank Rimerman Advisors LLC now owns 10,890 shares of the medical equipment provider’s stock valued at $5,684,000 after purchasing an additional 60 shares during the last quarter. First National Trust Co grew its holdings in Intuitive Surgical by 7.7% during the fourth quarter. First National Trust Co now owns 13,913 shares of the medical equipment provider’s stock valued at $7,262,000 after purchasing an additional 994 shares during the period. Midwest Professional Planners LTD. increased its position in Intuitive Surgical by 3.4% in the fourth quarter. Midwest Professional Planners LTD. now owns 3,033 shares of the medical equipment provider’s stock worth $1,583,000 after buying an additional 100 shares during the last quarter. Finally, Renasant Bank raised its stake in shares of Intuitive Surgical by 58.5% in the fourth quarter. Renasant Bank now owns 986 shares of the medical equipment provider’s stock valued at $515,000 after buying an additional 364 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.6 %

Shares of NASDAQ:ISRG opened at $484.44 on Monday. The stock has a market capitalization of $172.55 billion, a P/E ratio of 75.58, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The stock’s 50-day moving average price is $567.46 and its 200-day moving average price is $531.94. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several recent research reports. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Citigroup lifted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Piper Sandler reiterated an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Finally, Leerink Partners increased their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $613.10.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the transaction, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock worth $17,691,621 in the last ninety days. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.